| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..10517420L |
| P356 | DOI | 10.1073/PNAS.0710725105 |
| P8608 | Fatcat ID | release_ktw3yap2ynd67eiuryycbsyaqq |
| P3181 | OpenCitations bibliographic resource ID | 3401312 |
| P932 | PMC publication ID | 2582266 |
| P698 | PubMed publication ID | 18987311 |
| P5875 | ResearchGate publication ID | 23454531 |
| P2093 | author name string | Ling Lin | |
| Jian-Hua Zhang | |||
| William F Simonds | |||
| Leelamma M Panicker | |||
| P2860 | cites work | Parafibromin inhibits cancer cell growth and causes G1 phase arrest | Q24304063 |
| The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II | Q24304135 | ||
| The human PAF complex coordinates transcription with events downstream of RNA synthesis | Q24307917 | ||
| Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo | Q24319343 | ||
| Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II | Q24337471 | ||
| The parafibromin tumor suppressor protein is part of a human Paf1 complex | Q24557571 | ||
| Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) | Q24675703 | ||
| HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours | Q24676397 | ||
| Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression | Q33209570 | ||
| p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest | Q33925109 | ||
| HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome | Q34159232 | ||
| Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma | Q34273263 | ||
| Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. | Q34289020 | ||
| Hyperparathyroidism-jaw tumour syndrome | Q35130899 | ||
| Perturbations of the AKT signaling pathway in human cancer | Q36313181 | ||
| Intrinsic sites of transcription termination and pausing in the c-myc gene | Q36847325 | ||
| Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function | Q40168423 | ||
| Ras enhances Myc protein stability. | Q40967066 | ||
| c-myc protein expression in untransformed fibroblasts | Q41684755 | ||
| Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome | Q44258546 | ||
| Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors | Q45345276 | ||
| Ras mediates cell survival by regulating tuberin | Q46961792 | ||
| The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region | Q49162171 | ||
| Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. | Q54600169 | ||
| Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. | Q54617217 | ||
| Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. | Q64889594 | ||
| Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome | Q79832233 | ||
| Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation | Q80331561 | ||
| Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors | Q80974820 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | MYC proto-oncogene, bHLH transcription factor | Q420267 |
| Cell division cycle 73 | Q21113887 | ||
| LEO1 homolog, Paf1/RNA polymerase II complex component | Q21117100 | ||
| peroxisomal biogenesis factor 2 | Q21122491 | ||
| P304 | page(s) | 17420-5 | |
| P577 | publication date | 2008-11-11 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene | |
| P478 | volume | 105 |
| Q36086940 | A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair. |
| Q39097827 | An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region. |
| Q42128109 | BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen |
| Q47659761 | Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair |
| Q37278906 | CDC73 gene mutations in sporadic ossifying fibroma of the jaws |
| Q53350124 | Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. |
| Q33632809 | Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization |
| Q34125668 | Clinical and molecular genetics of parathyroid neoplasms |
| Q44004244 | Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome |
| Q36199639 | Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis |
| Q53228284 | Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis. |
| Q35029135 | Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. |
| Q34993892 | Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome |
| Q38023142 | Diagnosis and management of parathyroid cancer. |
| Q38761703 | Distinct roles of parafibromin in the extracellular environment, cytoplasm and nucleus of osteosarcoma cells |
| Q26747174 | Endocrine neoplasms in familial syndromes of hyperparathyroidism |
| Q64964682 | Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective. |
| Q30979173 | Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. |
| Q38895410 | GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. |
| Q27025359 | Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors |
| Q30360213 | Genomic profiling reveals mutational landscape in parathyroid carcinomas |
| Q33518904 | Human synthetic lethal inference as potential anti-cancer target gene detection |
| Q35067757 | Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene |
| Q35065497 | Identification of a role for histone H2B ubiquitylation in noncoding RNA 3'-end formation through mutational analysis of Rtf1 in Saccharomyces cerevisiae |
| Q36890205 | Menin mediates epigenetic regulation via histone H3 lysine 9 methylation |
| Q38193373 | Molecular profiling in primary hyperparathyroidism. |
| Q48112980 | PAF1 complex component Leo1 helps recruit Drosophila Myc to promoters. |
| Q55039489 | PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia. |
| Q43110166 | PLANT HOMOLOGOUS TO PARAFIBROMIN is a component of the PAF1 complex and assists in regulating expression of genes within H3K27ME3-enriched chromatin. |
| Q35583695 | Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics |
| Q89002627 | Primary Hyperparathyroidism Focused on Molecular Pathogenesis |
| Q35620388 | Protein Degradation of RNA Polymerase II-Association Factor 1(PAF1) Is Controlled by CNOT4 and 26S Proteasome |
| Q41908225 | SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver |
| Q35783618 | The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome |
| Q50457814 | The PAF1 complex is involved in embryonic epidermal morphogenesis in Caenorhabditis elegans |
| Q38627903 | The Paf1 complex represses SER3 transcription in Saccharomyces cerevisiae by facilitating intergenic transcription-dependent nucleosome occupancy of the SER3 promoter |
| Q37671309 | The Paf1 complex: platform or player in RNA polymerase II transcription? |
| Q47130466 | The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis |
| Q38858757 | The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas |
| Q36522035 | The many roles of the conserved eukaryotic Paf1 complex in regulating transcription, histone modifications, and disease states |
| Q45879500 | The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy |
| Q33608914 | The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression |
| Q33636429 | Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1 |
| Q24293440 | Transcriptional activators enhance polyadenylation of mRNA precursors |
| Q90388631 | ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation |
Search more.